Ammonium Lactate

Summary

Ammonium Lactate (CHEMBL1200747) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Clinical trials: 1
• Chemistry: 107.11 Da · C3H9NO3

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1200747
Name	Ammonium Lactate
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	10129918
Molecular formula	C3H9NO3
Molecular weight	107.11
InChIKey	RZOBLYBZQXQGFY-UHFFFAOYSA-N

SMILES: CC(C(=O)O)O.N

IUPAC name: azane;2-hydroxypropanoic acid

Also known as: Ammonium lactate, BMS-186091, E328, Lac hydrin, Lac-hydrin, NSC-760427, AMMONIUM LACTATE

Patent coverage: 2,515 distinct patent families (7,793 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 1.

Phase distribution

Phase	Trials
PHASE3	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT04127513	PHASE3	COMPLETED	Comparison of 12% Ammonium Lactate and 10% Urea Cream in Geriatric With Xerosis Cutis

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).